General
Preferred name
AMCASERTIB
Synonyms
BBI503 ()
PMID28460551-Compound-1 ()
BBI-503 ()
P&D ID
PD064943
CAS
1129403-56-0
Tags
available
drug candidate
Drug indication
Cholangiocarcinoma
Pancreatic cancer
Hepatocellular carcinoma
Colorectal cancer
Breast cancer
Solid tumour/cancer
Gastric adenocarcinoma
Prostate cancer
Lung cancer
Colon cancer
Ovarian cancer
Drug Status
investigational
Max Phase
2.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
5
Axon Medchem Screening Library
ChEMBL Drugs
DrugBank
PKIDB
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
13
Properties
(calculated by RDKit )
Molecular Weight
539.24
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
3
Rotatable Bonds
9
Ring Count
5
Aromatic Ring Count
4
cLogP
5.99
TPSA
90.12
Fraction CSP3
0.26
Chiral centers
0.0
Largest ring
6.0
QED
0.23
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
MOA
Stemness kinase
Pathway
Stem Cells
Target
Stemness kinase inhibitor
PDGFRA
Source data
